P. Villeneuve, Loi no2004-806 du 9 août 2004 relative à la politique de santé publique, LEGICOM, vol.38, issue.2, p.79, 2007.

M. C. Delmas and C. Fuhrman, L?asthme en France : synthèse des données épidémiologiques descriptives, Revue des Maladies Respiratoires, vol.27, issue.2, pp.151-159, 2010.

E. D. Bateman, S. S. Hurd, P. J. Barnes, and J. Bousquet, ?Global strategy for asthma management and prevention: GINA executive summary.? E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143?178., European Respiratory Journal, vol.51, issue.2, p.0751387, 2018.

K. R. Chapman, D. Hinds, P. Piazza, C. Raherison, M. Gibbs et al., Physician perspectives on the burden and management of asthma in six countries: The Global Asthma Physician Survey (GAPS), BMC Pulmonary Medicine, vol.17, issue.1, p.153, 2017.

, Analyse, conception et réalisation d?une application de base de données, Conception de bases de données avec UML, pp.347-446, 2007.

P. J. Barnes, Current issues for establishing inhaled corticosteroids as the antiinflammatory agents of choice in asthma, Journal of Allergy and Clinical Immunology, vol.101, issue.4, pp.S427-S433, 1998.

S. Suissa and P. Ernst, Inhaled corticosteroids: Impact on asthma morbidity and mortality, Journal of Allergy and Clinical Immunology, vol.107, issue.6, pp.937-944, 2001.

S. Baldacci, M. Simoni, S. Maio, A. Angino, F. Martini et al., Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice, Respiratory Medicine, vol.146, pp.10-17, 2019.

. Paris, Le Ménagier de Paris, Le Menagier de Paris, 1981.

F. Megas, K. Benmedjahed, G. Lefrançois, M. Mueser, and D. Dusser, Enquête « Compli?Asthme » : observance thérapeutique et bonne utilisation des médicaments inhalés dans l?asthme perçues par les médecins praticiens, Revue de Pneumologie Clinique, vol.60, issue.3, pp.158-165, 2004.

M. Masoli, D. Fabian, S. Holt, and R. Beasley, The global burden of asthma: executive summary of the GINA Dissemination Committee Report, Allergy, vol.59, issue.5, pp.469-478, 2004.

A. Gillissen and J. Lecheler, Kortikophobie beim Asthma bronchiale, Medizinische Klinik, vol.98, issue.8, pp.417-422, 2003.

D. J. Birnkrant, Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program Expert Panel, NIH, February, 1997, Clinical Pediatrics, vol.36, issue.12, pp.722-723, 1997.

. Anaes, Recommandations pour le suivi médical des patients asthmatiques adultes et adolescents, La Presse Médicale, vol.34, issue.4, pp.319-326, 2005.

B. Johnson, Spatial data available on the web at http://mrdata.usgs.gov/, Asthma. World Health Organization. Fact sheet, issue.307, 2002.

M. Masoli, D. Fabian, S. Holt, and R. Beasley, The global burden of asthma: executive summary of the GINA Dissemination Committee Report, Allergy, vol.59, issue.5, pp.469-478, 2004.

U. G. Lalloo, J. Malolepszy, D. Kozma, K. Krofta, J. Ankerst et al., Budesonide and Formoterol in a Single Inhaler Improves Asthma Control Compared With Increasing the Dose of Corticosteroid in Adults With Mild-to-Moderate Asthma, Chest, vol.123, issue.5, pp.1480-1487, 2003.

M. R. Sears, H. H. Hiller, G. D. Boer, R. Beaglehole, A. J. Gillies et al., ACCURACY OF CERTIFICATION OF DEATHS DUE TO ASTHMA, American Journal of Epidemiology, vol.124, issue.6, pp.1004-1011, 1986.

M. Sadatsafavi, R. Rousseau, W. Chen, W. Zhang, L. Lynd et al., The Preventable Burden of Productivity Loss Due to Suboptimal Asthma Control, Chest, vol.145, issue.4, pp.787-793, 2014.

, Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS), European Respiratory Journal, vol.9, issue.4, pp.687-695, 1996.

M. C. Delmas, A. Zeghnoun, and E. Jougla, Mortalité par asthme en France métropolitaine, BEH, vol.47, pp.221-224, 1980.

S. Salmeron, R. Liard, D. Elkharrat, J. Muir, F. Neukirch et al., Asthma severity and adequacy of management in accident and emergency departments in France: a prospective study, The Lancet, vol.358, issue.9282, pp.629-635, 2001.

S. Salmeron, ASUR - ASUR2 vers une standardisation de la prise en charge de l?Asthme aigu aux urgences, Revue des Maladies Respiratoires, vol.22, issue.2, pp.30-31, 2005.

C. Le-jeunne, Pharmacologie des glucocorticoïdes, La Presse Médicale, vol.41, issue.4, pp.370-377, 2012.

M. Kraft, R. Djukanovic, S. Wilson, S. T. Holgate, and R. J. Martin, Alveolar tissue inflammation in asthma., American Journal of Respiratory and Critical Care Medicine, vol.154, issue.5, pp.1505-1510, 1996.

A. M. Vignola, F. Mirabella, G. Costanzo, R. Di-giorgi, M. Gjomarkaj et al., Airway Remodeling in Asthma, Chest, vol.123, issue.3, pp.417S-422S, 2003.

. Advenier, La lettre du Pharmacologue, vol.7, issue.2, pp.24-28, 1993.

M. De and L. Santé, Programme d'actions, de prévention et de prise en charge de l' Asthme, 2002.

P. J. Barnes, S. Pedersen, and W. W. Busse, Efficacy and safety of inhaled corticosteroids. New developments, Am J Respir Crit Care Med, vol.157, pp.1-53, 1998.

S. Suissa, P. Ernst, S. Benayoun, M. Baltzan, and B. Cai, Low-dose inhaled corticosteroids and the prevention of death from asthma, N Engl J Med, vol.343, pp.332-338, 2000.

L. Tetû, R. Escamilla, and A. Didier, Corticoïdes inhalés : Quelle drogue? Quel système?

R. Buhl, Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma, Allergy, vol.61, issue.5, pp.518-526, 2006.

L. Fromer, Managing asthma: an evidence-based approach to optimizing inhaled corticosteroid treatment, South Med J, vol.103, pp.1038-1044, 2010.

M. E. Hejazi, Concurrent Use Of Metered Dose Inhalers Without Spacer And Dry Powder Inhalers By Asthmatic Children Adversely Affect Proper Inhalation Technique, The Internet Journal of Pediatrics and Neonatology, vol.13, issue.1, pp.9-16, 2011.

J. D. Skoner, T. J. Schaffner, C. A. Schad, A. Y. Kwon, and D. P. Skoner, Addressing steroid phobia: Improving the risk?benefit ratio with new agents, Allergy and Asthma Proceedings, vol.29, issue.4, pp.358-364, 2008.

H. W. Kelly and H. S. Nelson, Potential adverse effects of the inhaled corticosteroids, J Allergy Clin Immunol, vol.112, pp.469-478, 2003.

H. Derendorf, R. Nave, A. Drollmann, F. Cerasoli, and W. Wurst, Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma, European Respiratory Journal, vol.28, issue.5, pp.1042-1050, 2006.

E. Mutch, R. Nave, K. Zech, and F. M. Williams, Esterases involved in the hydrolysis of ciclesonide in human tissues, Eur Respir J, vol.22, pp.267-268, 2003.

G. Pelaia, A. Vatrella, G. Cuda, R. Maselli, and S. A. Marsico, Molecular mechanisms of corticosteroid actions in chronic inflammatory airway diseases, Life Sci, vol.72, pp.1549-1561, 2003.

P. J. Barnes, Effect of corticosteroids on airway hyperresponsiveness, Am Rev Respir Dis, vol.141, pp.70-76, 1990.

D. King, S. M. Earnshaw, and J. C. Delaney, Pressurised aerosol inhaler: the cost of misuse, Br J Clin Pratt, vol.45, pp.48-49, 1991.

C. K. Crompton, Problems patients have using pressurized aerosol inhalers, Eur J Respir Dis, vol.63, pp.101-104, 1982.

M. Partridge, Asthma: lessons from patient education, Patient Education and Counseling, vol.26, issue.1-3, pp.81-86, 1995.

R. Beasley, W. R. Roche, J. A. Roberts, and S. T. Holgate, Cellular events in the bronchi in mild asthma and after bronchial provocation, Am Rev Respir Dis, vol.139, pp.806-823, 1989.

J. Bousquet, P. Chanez, J. Y. Lacoste, G. Barneon, N. Ghavanian et al., Eosinophilic inflammation in asthma, N Engl J Med, vol.323, pp.1033-1042, 1990.

E. D. Bateman, H. A. Boushey, J. Bousquet, W. W. Busse, T. J. Clark et al., Can Guideline-defined Asthma Control Be Achieved?, American Journal of Respiratory and Critical Care Medicine, vol.170, issue.8, pp.836-844, 2004.

D. J. Jackson, L. B. Bacharier, and D. T. Mauger, Quintupling Inhaled Glucocorticoids to Prevent Childhood Asthma Exacerbations, N Engl J Med, vol.378, pp.891-901, 2018.

M. R. Partridge, T. Van-der-molen, S. E. Myrseth, and W. W. Busse, Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study, BMC Pulmonary Medicine, vol.6, issue.1, p.13, 2006.

S. Salmeron, A. Ellrodt, R. Liard, D. Elkharrat, J. F. Muir et al., Enquete multicentrique sur l'asthme aigu de l'adulte aux urgences: Resultats preliminaires, Réanimation Urgences, vol.7, issue.2, p.132, 1998.

N. Roche, C. Pribil, P. Devillier, and E. Van-ganse, Limited treatment adpatation despite poor asthma control in patients treated with inhaled corticosteroids, J Asthma, vol.53, pp.76-85, 2016.

M. Tada, T. Kuraki, and Y. Taooka, Comparison of clinical management of young and elderly asthmatics by respiratory specialists and general practitioners, J Asthma, vol.52, pp.162-169, 2015.

P. Godard, D. Huas, B. Sohier, C. Pribil, and I. Boucot, ER?Asthme, contrôle de l?asthme chez 16580 patients suivis en médecine générale, La Presse Médicale, vol.34, issue.19, pp.1351-1357, 2005.

K. F. Chung, G. Caramori, and I. M. Adcock, Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future, Eur J Clin Pharmacol, vol.65, pp.853-871, 2009.

C. J. Cates and T. J. Lasserson, Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events, Cochrane Database of Systematic Reviews, 2012.

J. Sweeney, C. C. Patterson, S. O'neill, C. O'neill, G. Plant et al., Inappropriate prescribing of combination inhalers in Northern Ireland: retrospective cross-sectional cohort study of prescribing practice in primary care, Primary Care Respiratory Journal, vol.23, issue.1, pp.74-78, 2014.

C. M. Blanchette, S. D. Culler, D. Ershoff, and B. Gutierrez, Association between previous health care use and initiation of inhaled corticosteroid and long-acting ?2-adrenergic agonist combination therapy among US patients with asthma, Clinical Therapeutics, vol.31, issue.11, pp.2574-2583, 2009.

M. Lugtenberg, J. S. Burgers, C. F. Besters, D. Han, and G. P. Westert, Perceived barriers to guideline adherence: A survey among general practitioners, BMC Family Practice, vol.12, issue.1, pp.12-98, 2011.

J. Braspenning, F. Schellevis, and R. Grol, Assessment of primary care by clinical quality indicators, Morbidity, Performance and Quality in Primary Care, pp.195-204, 2018.

R. Grol, Personal paper: Beliefs and evidence in changing clinical practice, BMJ, vol.315, issue.7105, pp.418-421, 1997.

M. Lugtenberg, J. M. Zegers-van-schaick, G. P. Westert, and J. S. Burgers, Why don't physicians adhere to guideline recommendations in practice? An analysis of barriers among Dutch general practitioners, Implementation Science, vol.4, issue.1, pp.54-69, 2009.

M. M. Cloutier, Asthma management programs for primary care providers, Current Opinion in Allergy and Clinical Immunology, vol.16, issue.2, pp.142-147, 2016.

F. Couturaud, A. Proust, I. Frachon, J. D. Dewitte, E. Oger et al., Education and Self-Management: A One-Year Randomized Trial in Stable Adult Asthmatic Patients, Journal of Asthma, vol.39, issue.6, pp.493-500, 2002.

L. Tuft, The Allergy Round Table Discussion Group, Allergy and Asthma Proceedings, vol.6, issue.3, pp.279-284, 1985.

T. J. David, Steroid scare., Archives of Disease in Childhood, vol.62, issue.9, pp.876-878, 1987.

R. Patterson, C. L. Walker, P. A. Greenberger, and E. P. Sheridan, Prednisonephobia, Allergy and Asthma Proceedings, vol.10, issue.6, pp.423-428, 1989.

J. Robert, V. Verdu, and F. Bérard,

L. P. Boulet, Perception of the Role and Potential Side Effects of Inhaled Corticosteroids Among Asthmatic Patients, Chest, vol.113, issue.3, pp.587-592, 1998.

S. Crone, M. R. Partridge, and F. Mcclean, National Alcohol Helpline, Psychiatric Bulletin, vol.17, issue.12, pp.725-725, 1993.

A. Perdoncini-roux, T. Blanchon, T. Hanslik, A. Lasserre, C. Turbelin et al., Perception par les médecins généralistes de la gêne induite par les effets indésirables d?une corticothérapie systémique prolongée, Revue d'Épidémiologie et de Santé Publique, vol.57, issue.2, pp.93-97, 2009.

L. P. Boulet, K. R. Chapman, L. W. Green, and J. M. Fitzgerald, Asthma Education, Chest, vol.106, issue.4, pp.184S-196S, 1994.

H. Brewis, Patient education, self-management plans and peak flow measurement, Respiratory Medicine, vol.85, issue.6, pp.457-462, 1991.

M. H. Becker and L. A. Maiman, Strategies for enhancing patient compliance, Journal of Community Health, vol.6, issue.2, pp.113-135, 1980.

K. R. Chapman, L. P. Boulet, R. M. Rea, and E. Franssen, Suboptimal asthma control: prevalence, detection and consequences in general practice, European Respiratory Journal, vol.31, issue.2, pp.320-325, 2008.

P. Demoly, K. Annunziata, E. Gubba, and L. Adamek, Repeated cross-sectional survey of patient-reported asthma control in Europe in the past 5 years, European Respiratory Review, vol.21, issue.123, pp.66-74, 2012.

I. Mitchell, S. C. Tough, L. K. Semple, F. H. Green, and P. A. Hessel, Near-Fatal Asthma, Chest, vol.121, issue.5, pp.1407-1413, 2002.

P. Demoly, P. Godard, and J. Bousquet, Une synthèse sur l'épidémiologie de l'asthme, Revue Française d'Allergologie et d'Immunologie Clinique, vol.45, issue.6, pp.464-475, 2005.

C. L. Armour, K. Lemay, B. Saini, H. K. Reddel, S. Z. Bosnic-anticevich et al., Using the Community Pharmacy to Identify Patients at Risk of Poor Asthma Control and Factors which Contribute to this Poor Control, Journal of Asthma, vol.48, issue.9, pp.914-922, 2011.

P. J. Barnes, The size of the problem of managing asthma, Respiratory Medicine, vol.98, pp.S4-S8, 2004.

J. M. Fitzgerlad, M. R. Sears, L. P. Boulet, A. B. Becker, A. R. Mcivor et al., Adjustable Maintenance Dosing with Budesonide/Formoterol Reduces Asthma Exacerbations Compared with Traditional Fixed Dosing: A Five-Month Multicentre Canadian Study, Canadian Respiratory Journal, vol.10, issue.8, pp.427-434, 2003.

J. D. Leuppi, M. Salzberg, and L. Meyer, An individualized, adjustable maintenance regimen of budesonide/formoterol provides effective asthma symptom control at a lower overall dose than fixed dosing, Swiss Med Wkly, vol.133, pp.302-311, 2003.

P. W. Ind, J. Haughney, D. Price, J. P. Rosen, and J. Kennelly, Adjustable and fixed dosing with budesonide/formoterol via a single inhaler in asthma patients: the ASSURE study, Respiratory Medicine, vol.98, issue.5, pp.464-475, 2004.

A. L. Caress, K. Beaver, K. Luker, M. Campbell, and A. Woodcock, Involvement in treatment decisions: what do adults with asthma want and what do they get? Results of a cross sectional survey, Thorax, vol.60, issue.3, pp.199-205, 2005.

H. Aubert and S. Barbarot, Non-adhésion et corticothérapie, Annales de Dermatologie et de Vénéréologie, vol.139, pp.S7-S12, 2012.

L. Letrilliart, I. Bourgeois, A. Vega, J. Cittée, and M. Lutsman, Première partie. Les voyelles, Glossaire du patois de Pierrecourt, vol.20, pp.3-23, 1913.

A. L. Strauss and J. M. Corbin, Basics of qualitative research: techniques and procedures for developing grounded theory, vol.342, 1998.

A. &. Aubin-auger, L. Baumann, A. M. Lehr-drylewicz, . Imbert, &. Patrick et al., Introduction, La recherche qualitative en éducation, vol.84, pp.1-4, 2011.

J. Mukamurera, F. Lacourse, and Y. Couturier, Des avancées en analyse qualitative: pour une transparence et une systématisation des pratiques, Recherches Qualitatives, vol.26, pp.110-148, 2006.

J. Natanson, L'évolution du concept de transfert chez Freud, Imaginaire & Inconscient, vol.2, issue.2, p.7, 2001.

M. Soulet, Traces et intuition raisonnée. Le paradigme indiciaire et la logique de la découverte en sciences sociales, Paillé P. (éd.). La Méthodologie qualitative. Posture de recherche et travail de terrain

A. Colin, , 2006.

J. F. Bervar, B. Chahine, T. , and I. , Des recommandations de consensus à la pratique: les zones d'ombre, Médecine Thérapeutique, vol.12, pp.41-46, 2006.

N. Roche and P. Godard, Le colloque : « Prise en charge de l?asthme : quel bilan à la fin du plan asthme ? » : introduction et points clés, Revue des Maladies Respiratoires, vol.22, issue.2, pp.7-12, 2005.

M. S. Broder, E. Y. Chang, C. Ory, T. Kamath, and S. Sapra, Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population, Allergy and Asthma Proceedings, vol.30, issue.2, pp.148-157, 2009.

J. Foucaud, M. Versel, O. Laügt, and A. Taytard, L?éducation thérapeutique du patient atteint de BPCO : le discours du médecin généraliste, Revue des Maladies Respiratoires, vol.22, issue.1, pp.55-62, 2005.

J. Pujet, C. Neijari, J. Tessier, M. Sapene, S. Pasquet et al., Diagnostic éducatif de l'asthme, Rev Mal Respir, vol.14, pp.209-226, 1997.

M. R. Partridge, Asthma Education: More Reading or More Viewing?, Journal of the Royal Society of Medicine, vol.79, issue.6, pp.326-328, 1986.

M. R. Partridge, S. R. Hill, . On, and . Working, Enhancing care for people with asthma: the role of communication, education, training and self-management, European Respiratory Journal, vol.16, issue.2, pp.333-349, 2000.

S. Takakura, T. Hasegawa, and K. Ishihara, Assessment of patients understanding of their asthmatic condition established in an outpatient clinic, Eur Respir J, vol.12, pp.29-53, 1998.

R. J. Adams, B. J. Smith, and R. E. Ruffin, Impact of the physician's participatory style in asthma outcomes and patient satisfaction, Annals of Allergy, Asthma & Immunology, vol.86, issue.3, pp.263-271, 2001.

P. G. Gibson, H. Powell, A. J. Wilson, M. J. Abramson, P. Haywood et al., Self-management education and regular practitioner review for adults with asthma, Cochrane Database of Systematic Reviews, p.3, 2002.

V. E. Murphy, P. G. Gibson, P. I. Talbot, C. G. Kessell, and V. L. Clifton, Asthma self-management skills and the use of asthma education during pregnancy, European Respiratory Journal, vol.26, issue.3, pp.435-441, 2005.

C. Raherisson, Place de l'éducation thérapeutique dans l'asthme sévère, Revue Française d'Allergologie et d'Immunologie Clinique, vol.46, issue.3, pp.145-147, 2006.